E16.3

Billable

Increased secretion of glucagon

Increased secretion of glucagon

Status

Billable / Specific

Block

E15-E16

Parent Code

E16

Coding Notes

Inclusion Terms

Alternative clinical terms for this condition

  • Hyperplasia of pancreatic endocrine cells with glucagon excess

Excludes 1

Codes that cannot be used together with this code (mutual exclusion)

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Also Known As / Clinical Terms

Frequently Asked Questions

What is ICD-10 code E16.3?

ICD-10-CM code E16.3 represents "Increased secretion of glucagon". It is a billable/specific code that can be used on a claim.

Is E16.3 a billable code?

Yes, E16.3 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

What chapter is E16.3 in?

E16.3 is in Chapter 4: Endocrine, Nutritional and Metabolic Diseases (codes E00-E89).

What codes cannot be used with E16.3?

E16.3 has Excludes1 notes indicating codes that cannot be used together with it, including: transitory endocrine and metabolic disorders specific to newborn (P70-P74).

What SNOMED CT codes does E16.3 map to?

E16.3 maps to 7 SNOMED CT concepts: 11178005, 190440000, 1228875006, 48839007, 87181002, and 2 more. SNOMED CT is a clinical terminology used in electronic health records.

What are the UMLS CUIs for E16.3?

E16.3 is linked to 2 UMLS Concept Unique Identifiers: C2874179, C0494303. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

Automate ICD-10 Coding With AI

Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.

Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.